Skip to main content

Day: August 26, 2022

RomReal: Second quarter (q2) 2022 Results and Investor Presentation

RomReal hereby announces the results of the second quarter 2022 via the Report and an Investor presentation attached to this message. For further information, pls contact investors@romreal.comThis information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentsRomReal Q2 2022 PresentationRomReal Q2 2022

Continue reading

India Okra Seed Market to Worth USD 148.45 Million by 2029 | Growing Area Under Okra Cultivation to Positively Influence the Market

Key companies covered in India okra seed market are UPL Limited (India), Mahyco Private Limited (India.), JK Agri Genetics Limited (India), Acsen HyVeg Pvt Ltd. (India), Nuziveedu Seeds Ltd. (India), Syngenta Group (Switzerland), Namdhari Seeds Pvt. Ltd. (India), BAYER AG (Germany), Ankur Seeds Pvt. Ltd. (India), BASF SE (Germany) & other Pune, India, Aug. 25, 2022 (GLOBE NEWSWIRE) — The global India okra seed market size hit USD 83.71 million in 2021. The market value is slated to rise from USD 87.12 million in 2022 to USD 148.45 million by 2029, exhibiting a CAGR of 7.91% during the forecast period, says Fortune Business Insights™ in its report titled, “India Okra Seed Market, 2022-2029”. Get a Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/india-okra-seed-market-106721 List of Key...

Continue reading

Junshi Biosciences Announces FDA Approval of Investigational New Drug Application for JS110 (XPO1 inhibitor)

— the 7th innovative drug in Junshi Biosciences’ pipeline to get IND approval from the US FDA SHANGHAI, China, Aug. 25, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that Suzhou Junjing Biomedical Technology Co., Ltd., a company jointly invested by Junshi Biosciences and Wigen Biomedicine Technology (Shanghai) Co., Ltd., has received a notice from the U.S. Food and Drug Administration (the “FDA”) concerning the approval of the investigational new drug (“IND”) application for XPO1 inhibitor WJ01024 tablets (product code: “JS110”) by the FDA. So far, 6 innovative drugs in Junshi Biosciences’ pipeline have obtained...

Continue reading

Onfolio Holdings Inc. Announces Pricing of $13.7 Million Initial Public Offering and Nasdaq Listing

NEW YORK, Aug. 25, 2022 (GLOBE NEWSWIRE) — Onfolio Holdings Inc. (“Onfolio” or the “Company”) (NASDAQ: ONFO, ONFOW), a holding company that acquires and manages a diversified portfolio of online businesses across a broad range of verticals, today announced the pricing of its initial public offering of 2,753,750 units, each consisting of one share of common stock (the “Common Stock”) and two warrants (the “Warrants”), each to purchase one share of common stock, at a public offering price of $5.00 per unit, for aggregate gross proceeds of approximately $13.7 million, prior to deducting underwriting discounts, commissions, and other offering expenses. Each unit will immediately separate into one share of Common Stock and two Warrants. Each Warrant permits the holder to purchase one share of Common Stock at an exercise price of $5.00...

Continue reading

Rubicon Organics Announces Resignation of Chief Executive Officer effective December 31st, 2022

VANCOUVER, British Columbia, Aug. 25, 2022 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified, premium cannabis, announces that Jesse McConnell, Co-Founder and Chief Executive Officer (“CEO”) of Rubicon Organics has provided his notice of resignation as CEO of the Company. Mr. McConnell is currently on parental leave and his resignation is anticipated to become effective on December 31, 2022. The Board of Directors of the Company will immediately begin a search for a successor who can lead the Company in driving forward its vision to be “the global brand leader in premium organic cannabis”. Mr. McConnell co-founded Rubicon Organics in June of 2015 with Peter Doig with a vision to provide leadership...

Continue reading

VSBLTY Reports Second Quarter 2022 Financial Results

Company Achieves Quarterly Revenue of $3.2M USD PHILADELPHIA, Aug. 25, 2022 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (OTCQB: VSBGF) (CSE: VSBY) (Frankfurt 5VS) (“VSBLTY”), a leading software provider of security and retail analytics technology, today announced its revenue for the second quarter of 2022 was $3.2 million (USD), which is a 161% percent increase over Q1 of 2022, and 10 times greater than the previous year’s Q2 of $293K, when the company began to scale its commercial operations. VSBLTY technology provides enhanced customer engagement and audience measurement using machine learning and computer vision. Its industry leading VisionCaptor™ and DataCaptor™ software combine motion graphics and interactive brand messaging with cutting-edge computer vision measurement and insights. VSBLTY’s AI driven software Vector™...

Continue reading

Nevada Copper Announces Restart Plan and Significant Proposed Financing Package

YERINGTON, Nev., Aug. 25, 2022 (GLOBE NEWSWIRE) — Nevada Copper (TSX: NCU) (OTC: NEVDF) (FSE: ZYTA) (“Nevada Copper” or the “Company”) is pleased to announce that it has agreed to non-binding terms with its key financing partners to provide up to US$93 million of liquidity to the Company in order to support the restart and ramp-up of the Company’s Pumpkin Hollow copper mine (the “Underground Mine”) located in Yerington, Nevada. The Company also announced the key components of its newly developed restart plan for the Underground Mine. Randy Buffington, Chief Executive Officer, stated: “I am very pleased with the substantial ongoing support of all our key stakeholders. The significant contribution by each of them is a testament to the conviction in the quality of the Pumpkin Hollow project and its intrinsic value. The current pause...

Continue reading

Canadian Spirit Resources Inc. Announces Second Quarter 2022 Financial Results and Operational Update

CALGARY, Alberta, Aug. 25, 2022 (GLOBE NEWSWIRE) — Canadian Spirit Resources Inc. (“CSRI” or the “Corporation”) (TSXV:SPI) (OTCBB:CSPUF) announces the release of its interim financial results and Management Discussion and Analysis (“MD&A”), for the three and six month periods ended June 30, 2022. Second Quarter 2022This news release summarizes information contained in the unaudited interim financial statements and MD&A for the three and six month periods ended June 30, 2022 and should not be considered a substitute for reading these full disclosure documents which are available on SEDAR at www.sedar.com. The following summarizes certain selected financial data for the three and six months ended June 30, 2022:(all amounts are presented in Canadian dollars, unless otherwise indicated)  Three...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.